Brain study of social perception in Parkinson's disease
Part of Brain & nervous system clinical trials.
This study uses brain scans to understand how people with Parkinson's disease process social cues, like faces and emotions. It may help researchers learn more about how Parkinson's affects social thinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 75 years old.
- You have been diagnosed with Parkinson's disease for at least 3 years and are taking Parkinson's medication.
- You can have an MRI scan (no metal implants, pacemaker, or severe claustrophobia).
- You do not have significant memory or thinking problems (MOCA score of 26 or higher).
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research uses brain imaging scans to study how a chemical messenger in the brain (called noradrenaline) changes as people age and in Parkinson's disease. The goal is to better understand how this brain system works and may help develop future treatments.
This study uses a special 7‑Tesla MRI brain scan to measure tiny chemical (metabolite) differences in specific deep brain areas. It compares newly diagnosed, early-stage Parkinson’s patients who are not on Parkinson medication with healthy volunteers.
This study uses brain scans to understand Parkinson's disease. It compares people with Parkinson's to healthy volunteers to learn how the brain changes.
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
This study uses MRI scans to look at dopamine signals in the brain. The goal is to understand how Parkinson's affects these signals.
This study uses advanced brain scans to find early signs of nerve damage in people with Parkinson's disease, progressive supranuclear palsy, and healthy volunteers. It aims to discover new markers that could help diagnose these conditions earlier.
Hear when a new Social Perception in Parkinson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.